CUSIP 29261A100 · who reports it, how much, and how much it matters to them
43 of the 720 hedge fund managers we track reported shares of Encompass Health Corp (NYSE: EHC) on Form 13F for 30 June 2026. Between them they reported USD 966m. The largest position belongs to Citadel Advisors, at USD 259m. The manager with the most riding on it is Eversept Partners, where it is 5.4% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Citadel Advisors32 funds on PPLI.com | USD 259m | 0.0% |
| 2 | Two Sigma Investments35 funds on PPLI.com | USD 229m | 0.2% |
| 3 | Eversept Partners3 funds on PPLI.com | USD 104m | 5.4% |
| 4 | Holocene Advisors2 funds on PPLI.com | USD 99m | 0.2% |
| 5 | Millennium Management6 funds on PPLI.com | USD 81m | 0.0% |
| 6 | D. E. Shaw & Co.15 funds on PPLI.com | USD 39m | 0.0% |
| 7 | Freestone Grove Partners1 fund on PPLI.com | USD 39m | 0.2% |
| 8 | Balyasny Asset Management25 funds on PPLI.com | USD 30m | 0.0% |
| 9 | Renaissance Technologies13 funds on PPLI.com | USD 18m | 0.0% |
| 10 | Adage Capital Management1 fund on PPLI.com | USD 11m | 0.0% |
| 11 | Exoduspoint Capital Management7 funds on PPLI.com | USD 9.4m | 0.1% |
| 12 | Voloridge Investment Management6 funds on PPLI.com | USD 9.4m | 0.0% |
| 13 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 5.5m | 0.0% |
| 14 | Bridgewater Associates45 funds on PPLI.com | USD 4.1m | 0.0% |
| 15 | Verition Fund Management3 funds on PPLI.com | USD 4m | 0.0% |
| 16 | Capital Fund Management S.A.12 funds on PPLI.com | USD 3.4m | 0.0% |
| 17 | Engineers Gate Manager1 fund on PPLI.com | USD 2.7m | 0.0% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 2.5m | 0.0% |
| 19 | Prescott Group Capital Management3 funds on PPLI.com | USD 2m | 0.2% |
| 20 | Polar Capital LLP26 funds on PPLI.com | USD 1.9m | 0.0% |
| 21 | Capricorn Fund Managers8 funds on PPLI.com | USD 1.9m | 0.1% |
| 22 | Dark Forest Capital Management2 funds on PPLI.com | USD 1.8m | 0.1% |
| 23 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 1.4m | 0.1% |
| 24 | Formula Growth6 funds on PPLI.com | USD 1m | 0.4% |
| 25 | Entrypoint Capital1 fund on PPLI.com | USD 820,000 | 0.2% |
| 26 | Scientech Research2 funds on PPLI.com | USD 678,000 | 0.5% |
| 27 | Diametric Capital2 funds on PPLI.com | USD 613,000 | 0.1% |
| 28 | Landscape Capital Management4 funds on PPLI.com | USD 601,000 | 0.0% |
| 29 | Mangrove Partners Im1 fund on PPLI.com | USD 560,000 | 0.0% |
| 30 | Gamco Asset Management1 fund on PPLI.com | USD 557,000 | 0.0% |
| 31 | Weiss Asset Management5 funds on PPLI.com | USD 364,000 | 0.0% |
| 32 | Oxford Asset Management LLP2 funds on PPLI.com | USD 360,000 | 0.2% |
| 33 | Capstone Investment Advisors25 funds on PPLI.com | USD 345,000 | 0.0% |
| 34 | CIBC Asset Management69 funds on PPLI.com | USD 311,000 | 0.0% |
| 35 | Lecap Asset Management1 fund on PPLI.com | USD 226,000 | 0.1% |
| 36 | Marshall Wace LLP84 funds on PPLI.com | USD 225,000 | 0.0% |
| 37 | Boothbay Fund Management2 funds on PPLI.com | USD 211,000 | 0.0% |
| 38 | Graticule Asia Macro Advisors8 funds on PPLI.com | USD 190,000 | 0.0% |
| 39 | Bayforest Capital1 fund on PPLI.com | USD 88,243 | 0.1% |
| 40 | Wolverine Asset Management1 fund on PPLI.com | USD 81,066 | 0.0% |
| 41 | Persistent Asset Partners10 funds on PPLI.com | USD 35,883 | 0.0% |
| 42 | Walleye Capital8 funds on PPLI.com | USD 22,642 | 0.0% |
| 43 | The Quarry1 fund on PPLI.com | USD 2,123 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Eversept Partners | USD 104m | 5.4% |
| 2 | Scientech Research | USD 678,000 | 0.5% |
| 3 | Formula Growth | USD 1m | 0.4% |
| 4 | Freestone Grove Partners | USD 39m | 0.2% |
| 5 | Holocene Advisors | USD 99m | 0.2% |
| 6 | Entrypoint Capital | USD 820,000 | 0.2% |
| 7 | Oxford Asset Management LLP | USD 360,000 | 0.2% |
| 8 | Prescott Group Capital Management | USD 2m | 0.2% |
| 9 | Two Sigma Investments | USD 229m | 0.2% |
| 10 | Capricorn Fund Managers | USD 1.9m | 0.1% |
Encompass Health Corp trades under the symbol EHC on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 29261A100.
43 of the 720 hedge fund managers PPLI.com tracks reported Encompass Health Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 259m), Two Sigma Investments (USD 229m), Eversept Partners (USD 104m), Holocene Advisors (USD 99m) and Millennium Management (USD 81m).
43 managers in our coverage reported it, and between them they run 525 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Eversept Partners, where the position was 5.4% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Encompass Health Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.